$SCYX
SCYNEXIS Inc Stock $scyx

$scyx Overview Financials Valuation SEC Filings Company Website

2015 Q1 Form 8-K Financial Statement

#000117825315000118 Filed on October 30, 2015

Income Statement

Concept	2015 Q1	2014 Q4	2014 Q1
Revenue	$65.00K	$1.060M	$65.00K
YoY Change	0.0%	-71.12%	-98.65%
Cost Of Revenue	$3.231M		$3.960M
YoY Change	-18.41%		-4.58%
Gross Profit	$66.00K		$745.0K
YoY Change	-91.14%		14.62%
Gross Profit Margin	101.54%		1146.15%
Selling, General & Admin	$2.210M	$2.030M	$1.206M
YoY Change	83.25%	65.04%	10.64%
% of Gross Profit	3348.48%		161.88%
Research & Development	$3.787M	$2.670M	$1.320M
YoY Change	186.89%	130.17%	14.78%
% of Gross Profit	5737.88%		177.18%
Depreciation & Amortization	$323.0K	$320.0K	$308.0K
YoY Change	4.87%		-12.0%
% of Gross Profit	489.39%		41.34%
Operating Expenses	$5.997M	$4.700M	$2.526M
YoY Change	137.41%	95.83%	12.77%
Operating Profit	-$5.932M		-$2.461M
YoY Change	141.04%		54.78%
Interest Expense	$1.000K	$0.00	-$44.00K
YoY Change	-102.27%	-100.0%	-95.56%
% of Operating Profit
Other Income/Expense, Net	$1.000K	$0.00	$2.193M
YoY Change	-99.95%
Pretax Income	-$5.931M	-$3.640M	-$268.0K
YoY Change	2113.06%	-83.25%	-87.05%
Income Tax	$0.00	-$260.0K	-$313.0K
% Of Pretax Income
Net Earnings	-$6.384M	-$3.080M	$412.0K
YoY Change	-1649.51%	-85.83%	-119.9%
Net Earnings / Revenue	-9821.54%	-290.57%	633.85%
Basic Earnings Per Share	-$0.75		-$3.65
Diluted Earnings Per Share	-$0.75	-$3.624M	-$6.57
COMMON SHARES
Basic Shares Outstanding	8.516M shares	8.512M shares	334.1K shares
Diluted Shares Outstanding	8.516M shares		609.1K shares

Balance Sheet

Concept	2015 Q1	2014 Q4	2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$27.60M	$32.20M	$700.0K
YoY Change	3842.86%
Cash & Equivalents	$27.62M	$32.24M	$650.0K
Short-Term Investments
Other Short-Term Assets	$420.0K	$3.000K	$700.0K
YoY Change	-40.0%	-40.0%
Inventory
Prepaid Expenses
Receivables	$681.0K	$1.118M	$900.0K
Other Receivables	$0.00		$0.00
Total Short-Term Assets	$34.57M	$39.65M	$2.300M
YoY Change	1402.96%	369.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$0.00	$0.00	$5.300M
YoY Change	-100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$32.00K	$25.00K	$5.400M
YoY Change	-99.41%	0.0%
Total Long-Term Assets	$289.0K	$25.00K	$10.70M
YoY Change	-97.3%	-99.37%
TOTAL ASSETS
Total Short-Term Assets	$34.57M	$39.65M	$2.300M
Total Long-Term Assets	$289.0K	$25.00K	$10.70M
Total Assets	$34.86M	$39.67M	$13.00M
YoY Change	168.13%	220.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$903.0K	$426.0K	$2.700M
YoY Change	-66.56%	-71.99%
Accrued Expenses	$3.060M	$2.245M	$1.600M
YoY Change	91.25%	206.69%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00	$15.00M
YoY Change		-100.0%
Total Short-Term Liabilities	$6.591M	$5.348M	$20.50M
YoY Change	-67.85%	-73.2%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.300M	$900.0K	$12.90M
YoY Change	-82.17%
Total Long-Term Liabilities	$2.300M	$900.0K	$12.90M
YoY Change	-82.17%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.591M	$5.348M	$20.50M
Total Long-Term Liabilities	$2.300M	$900.0K	$12.90M
Total Liabilities	$7.419M	$6.241M	$33.40M
YoY Change	-77.79%	-81.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$123.9M	-$117.5M
YoY Change		3.74%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$27.44M	$33.43M	-$20.40M
YoY Change
Total Liabilities & Shareholders Equity	$34.86M	$39.67M	$13.00M
YoY Change	168.13%	220.27%

Cashflow Statement

Concept	2015 Q1	2014 Q4	2014 Q1
OPERATING ACTIVITIES
Net Income	-$6.384M	-$3.080M	$412.0K
YoY Change	-1649.51%	-85.83%	-119.9%
Depreciation, Depletion And Amortization	$323.0K	$320.0K	$308.0K
YoY Change	4.87%		-12.0%
Cash From Operating Activities	-$4.547M	-$1.720M	$3.140M
YoY Change	-244.81%		-269.73%
INVESTING ACTIVITIES
Capital Expenditures	$171.0K	-$70.00K	$74.00K
YoY Change	131.08%		-127.41%
Acquisitions
YoY Change
Other Investing Activities		$0.00	-$990.0K
YoY Change			-294.12%
Cash From Investing Activities	-$171.0K	-$70.00K	-$690.0K
YoY Change	-75.22%		-376.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$95.00K	0.000	-1.740M
YoY Change	-105.46%
NET CHANGE
Cash From Operating Activities	-$4.547M	-1.720M	3.140M
Cash From Investing Activities	-$171.0K	-70.00K	-690.0K
Cash From Financing Activities	$95.00K	0.000	-1.740M
Net Change In Cash	-$4.623M	-1.790M	710.0K
YoY Change	-751.13%		-144.38%
FREE CASH FLOW
Cash From Operating Activities	-$4.547M	-$1.720M	$3.140M
Capital Expenditures	$171.0K	-$70.00K	$74.00K
Free Cash Flow	-$4.718M	-$1.650M	$3.066M
YoY Change	-253.88%		-294.05%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q1	dei	Amendment Flag AmendmentFlag	false
CY2015Q1	dei	Document Period End Date DocumentPeriodEndDate	2015-03-31
CY2015Q1	dei	Document Type DocumentType	8-K
CY2015Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001178253
CY2015Q1	dei	Entity Registrant Name EntityRegistrantName	SCYNEXIS INC
CY2013Q4	scyx	Accrued Researchand Development Expense Current AccruedResearchandDevelopmentExpenseCurrent	92000	USD
CY2014Q4	scyx	Accrued Researchand Development Expense Current AccruedResearchandDevelopmentExpenseCurrent	293000	USD
CY2014Q1	scyx	Income Lossfrom Continuing Operations Attributableto Parent Basic IncomeLossfromContinuingOperationsAttributabletoParentBasic	-1588000	USD
CY2014	scyx	Derivative Fair Value Gain Loss From Mark To Market Adjustment DerivativeFairValueGainLossFromMarkToMarketAdjustment	-10442000	USD
CY2013	scyx	Disposal Group Including Discontinued Operations Licenseand Services Revenue DisposalGroupIncludingDiscontinuedOperationsLicenseandServicesRevenue	62000	USD
CY2014	scyx	Disposal Group Including Discontinued Operations Licenseand Services Revenue DisposalGroupIncludingDiscontinuedOperationsLicenseandServicesRevenue	122000	USD
CY2013	scyx	Effective Income Tax Rate Reconciliation Beneficial Conversion Featureon Convertible Notes Amount EffectiveIncomeTaxRateReconciliationBeneficialConversionFeatureonConvertibleNotesAmount	3673000	USD
CY2014	scyx	Effective Income Tax Rate Reconciliation Beneficial Conversion Featureon Convertible Notes Amount EffectiveIncomeTaxRateReconciliationBeneficialConversionFeatureonConvertibleNotesAmount	0	USD
CY2013	scyx	Effective Income Tax Rate Reconciliation Beneficial Conversion Featureon Convertible Notes Percent EffectiveIncomeTaxRateReconciliationBeneficialConversionFeatureonConvertibleNotesPercent	-0.115
CY2014	scyx	Effective Income Tax Rate Reconciliation Beneficial Conversion Featureon Convertible Notes Percent EffectiveIncomeTaxRateReconciliationBeneficialConversionFeatureonConvertibleNotesPercent	0.000
CY2013	scyx	Effective Income Tax Rate Reconciliation Deemed Contribution Interest Amount EffectiveIncomeTaxRateReconciliationDeemedContributionInterestAmount	1516000	USD
CY2014	scyx	Effective Income Tax Rate Reconciliation Deemed Contribution Interest Amount EffectiveIncomeTaxRateReconciliationDeemedContributionInterestAmount	0	USD
CY2013	scyx	Effective Income Tax Rate Reconciliation Deemed Contribution Interest Percent EffectiveIncomeTaxRateReconciliationDeemedContributionInterestPercent	-0.048
CY2014	scyx	Effective Income Tax Rate Reconciliation Deemed Contribution Interest Percent EffectiveIncomeTaxRateReconciliationDeemedContributionInterestPercent	0.000
CY2013	scyx	Effective Income Tax Rate Reconciliation Expirationof Capital Loss Carryforward Amount EffectiveIncomeTaxRateReconciliationExpirationofCapitalLossCarryforwardAmount	1511000	USD
CY2014	scyx	Effective Income Tax Rate Reconciliation Expirationof Capital Loss Carryforward Amount EffectiveIncomeTaxRateReconciliationExpirationofCapitalLossCarryforwardAmount	0	USD
CY2013	scyx	Effective Income Tax Rate Reconciliation Expirationof Capital Loss Carryforward Percent EffectiveIncomeTaxRateReconciliationExpirationofCapitalLossCarryforwardPercent	-0.047
CY2014	scyx	Effective Income Tax Rate Reconciliation Expirationof Capital Loss Carryforward Percent EffectiveIncomeTaxRateReconciliationExpirationofCapitalLossCarryforwardPercent	0.000
CY2013	scyx	Effective Income Tax Rate Reconciliation Stock Warrant Derivative Liability Amount EffectiveIncomeTaxRateReconciliationStockWarrantDerivativeLiabilityAmount	2686000	USD
CY2014	scyx	Effective Income Tax Rate Reconciliation Stock Warrant Derivative Liability Amount EffectiveIncomeTaxRateReconciliationStockWarrantDerivativeLiabilityAmount	-3427000	USD
CY2013	scyx	Effective Income Tax Rate Reconciliation Stock Warrant Derivative Liability Percent EffectiveIncomeTaxRateReconciliationStockWarrantDerivativeLiabilityPercent	-0.084
CY2014	scyx	Effective Income Tax Rate Reconciliation Stock Warrant Derivative Liability Percent EffectiveIncomeTaxRateReconciliationStockWarrantDerivativeLiabilityPercent	0.506
CY2013	scyx	Excess Of Fair Value Warrants Over Proceeds ExcessOfFairValueWarrantsOverProceeds	-1714000	USD
CY2014Q1	scyx	Excess Of Fair Value Warrants Over Proceeds ExcessOfFairValueWarrantsOverProceeds	362000	USD
CY2014	scyx	Excess Of Fair Value Warrants Over Proceeds ExcessOfFairValueWarrantsOverProceeds	362000	USD
CY2013	scyx	Fair Value Of Warrants Allocated To Debt Discount FairValueOfWarrantsAllocatedToDebtDiscount	1168000	USD
CY2014	scyx	Fair Value Of Warrants Allocated To Debt Discount FairValueOfWarrantsAllocatedToDebtDiscount	906000	USD
CY2013	scyx	Income Lossfrom Continuing Operations Attributableto Parent Basic IncomeLossfromContinuingOperationsAttributabletoParentBasic	-47679000	USD
CY2014	scyx	Income Lossfrom Continuing Operations Attributableto Parent Basic IncomeLossfromContinuingOperationsAttributabletoParentBasic	-7236000	USD
CY2015Q1	scyx	Income Lossfrom Continuing Operations Attributableto Parent Basic IncomeLossfromContinuingOperationsAttributabletoParentBasic	-5931000	USD
CY2013	scyx	Income Lossfrom Continuing Operations Attributableto Parent Diluted IncomeLossfromContinuingOperationsAttributabletoParentDiluted	-47679000	USD
CY2014Q1	scyx	Income Lossfrom Continuing Operations Attributableto Parent Diluted IncomeLossfromContinuingOperationsAttributabletoParentDiluted	-4371000	USD
CY2014	scyx	Income Lossfrom Continuing Operations Attributableto Parent Diluted IncomeLossfromContinuingOperationsAttributabletoParentDiluted	-17316000	USD
CY2015Q1	scyx	Income Lossfrom Continuing Operations Attributableto Parent Diluted IncomeLossfromContinuingOperationsAttributabletoParentDiluted	-5931000	USD
CY2013	scyx	Deemed Dividend For Antidilution Adjustments To Convertible Preferred Stock DeemedDividendForAntidilutionAdjustmentsToConvertiblePreferredStock	6402000	USD
CY2014	scyx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-187000	USD
CY2014Q1	scyx	Deemed Dividend For Antidilution Adjustments To Convertible Preferred Stock DeemedDividendForAntidilutionAdjustmentsToConvertiblePreferredStock	214000	USD
CY2014	scyx	Deemed Dividend For Antidilution Adjustments To Convertible Preferred Stock DeemedDividendForAntidilutionAdjustmentsToConvertiblePreferredStock	214000	USD
CY2015Q1	scyx	Deemed Dividend For Antidilution Adjustments To Convertible Preferred Stock DeemedDividendForAntidilutionAdjustmentsToConvertiblePreferredStock	0	USD
CY2013	scyx	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	1233000	USD
CY2014Q1	scyx	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	1715000	USD
CY2014	scyx	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	0	USD
CY2015Q1	scyx	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	257000	USD
CY2013	scyx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-53000	USD
CY2014Q1	scyx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-15000	USD
CY2014Q4	scyx	Additional Milestone Payments Maximum AdditionalMilestonePaymentsMaximum	2300000	USD
CY2015Q1	scyx	Additional Milestone Payments Maximum AdditionalMilestonePaymentsMaximum	2300000	USD
CY2013	scyx	Adjustmentsto Additional Paidin Capital Stock Issued During Period Beneficial Conversion Feature AdjustmentstoAdditionalPaidinCapitalStockIssuedDuringPeriodBeneficialConversionFeature	-4232000	USD
CY2014	scyx	Adjustmentsto Additional Paidin Capital Stock Issued During Period Beneficial Conversion Feature AdjustmentstoAdditionalPaidinCapitalStockIssuedDuringPeriodBeneficialConversionFeature	-909000	USD
CY2013	scyx	Adjustmentto Additional Paidin Capital Beneficial Conversion Feature Antidilution Adjustment AdjustmenttoAdditionalPaidinCapitalBeneficialConversionFeatureAntidilutionAdjustment	-6402000	USD
CY2014	scyx	Adjustmentto Additional Paidin Capital Beneficial Conversion Feature Antidilution Adjustment AdjustmenttoAdditionalPaidinCapitalBeneficialConversionFeatureAntidilutionAdjustment	-214000	USD
CY2013	scyx	Adjustmentto Additional Paidin Capital Deemed Contribution AdjustmenttoAdditionalPaidinCapitalDeemedContribution	3930000	USD
CY2014Q2	scyx	Adjustmentto Additional Paidin Capital Reclassificationof Warrant Derivative Liability AdjustmenttoAdditionalPaidinCapitalReclassificationofWarrantDerivativeLiability	2701000	USD
CY2013	scyx	Adjustmentto Additional Paidin Capital Reclassificationof Warrant Derivative Liability AdjustmenttoAdditionalPaidinCapitalReclassificationofWarrantDerivativeLiability	0	USD
CY2014	scyx	Adjustmentto Additional Paidin Capital Reclassificationof Warrant Derivative Liability AdjustmenttoAdditionalPaidinCapitalReclassificationofWarrantDerivativeLiability	2701000	USD
CY2014	scyx	Adjustmentto Additional Periodin Capital Exerciseof Warrants AdjustmenttoAdditionalPeriodinCapitalExerciseofWarrants	55000	USD
CY2013Q4	scyx	Common Stock Capital Shares Reserved For Future Issuance For Conversion Of Preferred Stock And Exercise Of Warrants CommonStockCapitalSharesReservedForFutureIssuanceForConversionOfPreferredStockAndExerciseOfWarrants	1675812	shares
CY2014Q4	scyx	Common Stock Capital Shares Reserved For Future Issuance For Conversion Of Preferred Stock And Exercise Of Warrants CommonStockCapitalSharesReservedForFutureIssuanceForConversionOfPreferredStockAndExerciseOfWarrants	0	shares
CY2013Q4	scyx	Common Stock Capital Shares Reserved For Future Issuance Of Exercise Of Outstanding Warrants CommonStockCapitalSharesReservedForFutureIssuanceOfExerciseOfOutstandingWarrants	257242	shares
CY2014Q4	scyx	Common Stock Capital Shares Reserved For Future Issuance Of Exercise Of Outstanding Warrants CommonStockCapitalSharesReservedForFutureIssuanceOfExerciseOfOutstandingWarrants	0	shares
CY2013	scyx	Deemed Contribution Of Loan Guarantee DeemedContributionOfLoanGuarantee	3930000	USD
CY2014	scyx	Deemed Contribution Of Loan Guarantee DeemedContributionOfLoanGuarantee	0	USD
CY2013	scyx	Deemed Dividend Associated With Beneficial Conversion Of Convertible Preferred Stock DeemedDividendAssociatedWithBeneficialConversionOfConvertiblePreferredStock	4232000	USD
CY2014Q1	scyx	Deemed Dividend Associated With Beneficial Conversion Of Convertible Preferred Stock DeemedDividendAssociatedWithBeneficialConversionOfConvertiblePreferredStock	909000	USD
CY2014	scyx	Deemed Dividend Associated With Beneficial Conversion Of Convertible Preferred Stock DeemedDividendAssociatedWithBeneficialConversionOfConvertiblePreferredStock	909000	USD
CY2015Q1	scyx	Deemed Dividend Associated With Beneficial Conversion Of Convertible Preferred Stock DeemedDividendAssociatedWithBeneficialConversionOfConvertiblePreferredStock	0	USD
CY2013	scyx	Deferred Offering Costs Reclassified To Additional Paid In Capital DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital	0	USD
CY2014	scyx	Deferred Offering Costs Reclassified To Additional Paid In Capital DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital	4126000	USD
CY2012Q3	scyx	Deferred Revenue Recognition Period DeferredRevenueRecognitionPeriod	P6M
CY2013Q3	scyx	Deferred Revenue Recognition Period DeferredRevenueRecognitionPeriod	P70M
CY2014Q1	scyx	Deferred Revenue Recognition Period DeferredRevenueRecognitionPeriod	P48M
CY2013Q4	scyx	Deferred Tax Assets Held For Sale Net Of Liabilities DeferredTaxAssetsHeldForSaleNetOfLiabilities	1938000	USD
CY2014Q4	scyx	Deferred Tax Assets Held For Sale Net Of Liabilities DeferredTaxAssetsHeldForSaleNetOfLiabilities	1882000	USD
CY2013Q4	scyx	Deferred Tax Assets Netof Liabilities Gross DeferredTaxAssetsNetofLiabilitiesGross	30675000	USD
CY2014Q4	scyx	Deferred Tax Assets Netof Liabilities Gross DeferredTaxAssetsNetofLiabilitiesGross	35950000	USD
CY2013Q4	scyx	Deferred Tax Assets Netof Liabilities Gross Current DeferredTaxAssetsNetofLiabilitiesGrossCurrent	2816000	USD
CY2014Q4	scyx	Deferred Tax Assets Netof Liabilities Gross Current DeferredTaxAssetsNetofLiabilitiesGrossCurrent	3285000	USD
CY2013Q4	scyx	Deferred Tax Assets Netof Liabilities Gross Noncurrent DeferredTaxAssetsNetofLiabilitiesGrossNoncurrent	27859000	USD
CY2014Q4	scyx	Deferred Tax Assets Netof Liabilities Gross Noncurrent DeferredTaxAssetsNetofLiabilitiesGrossNoncurrent	32665000	USD
CY2014	scyx	Defined Contribution Plan Employers Matching Contribution Vesting Period DefinedContributionPlanEmployersMatchingContributionVestingPeriod	P4Y
CY2014	scyx	Defined Contribution Plan Required Work Hours Per Week DefinedContributionPlanRequiredWorkHoursPerWeek	20	H
CY2013	scyx	Derivative Fair Value Gain Loss From Mark To Market Adjustment DerivativeFairValueGainLossFromMarkToMarketAdjustment	7886000	USD
CY2014Q1	scyx	Derivative Fair Value Gain Loss From Mark To Market Adjustment DerivativeFairValueGainLossFromMarkToMarketAdjustment	-3145000	USD
CY2015Q1	scyx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-57000	USD
CY2013	scyx	Interest Expense Beneficial Conversion Feature InterestExpenseBeneficialConversionFeature	10802000	USD
CY2014	scyx	Interest Expense Beneficial Conversion Feature InterestExpenseBeneficialConversionFeature	0	USD
CY2014Q1	scyx	Ipo Gross Proceeds Threshold That Triggers Automatic Conversion Of Preferred Stock IpoGrossProceedsThresholdThatTriggersAutomaticConversionOfPreferredStock	20000000	USD
CY2014Q2	scyx	Issuance Of Common Stock Pursuant To Conversion Of Warrants Shares IssuanceOfCommonStockPursuantToConversionOfWarrantsShares	275687	shares
CY2014Q2	scyx	Issuance Of Common Stock Pursuant To Conversion Of Warrants Shares IssuanceOfCommonStockPursuantToConversionOfWarrantsShares	275687	shares
CY2014Q2	scyx	Issuance Of Common Stock Pursuant To Conversion Of Warrants Shares IssuanceOfCommonStockPursuantToConversionOfWarrantsShares	275687	shares
CY2014	scyx	Issuance Of Common Stock Pursuant To Conversion Of Warrants Shares IssuanceOfCommonStockPursuantToConversionOfWarrantsShares	275687	shares
CY2013	scyx	Issuanceof Warrantswith Preferred Stock IssuanceofWarrantswithPreferredStock	2500000	USD
CY2014Q1	scyx	Issuanceof Warrantswith Preferred Stock IssuanceofWarrantswithPreferredStock	544000	USD
CY2014	scyx	Issuanceof Warrantswith Preferred Stock IssuanceofWarrantswithPreferredStock	0	USD
CY2015Q1	scyx	Issuanceof Warrantswith Preferred Stock IssuanceofWarrantswithPreferredStock	0	USD
CY2014	scyx	Lease Expiration Extension Date Under Option LeaseExpirationExtensionDateUnderOption	2024-03-31
CY2015Q1	scyx	Lease Expiration Extension Date Under Option LeaseExpirationExtensionDateUnderOption	2024-03-31
CY2014	scyx	Lease Expiration Year LeaseExpirationYear	2019
CY2015Q1	scyx	Lease Expiration Year LeaseExpirationYear	2019
CY2014	scyx	Milestone Payments MilestonePayments	19000000	USD
CY2015Q1	scyx	Milestone Payments MilestonePayments	19000000	USD
CY2014Q4	scyx	Number Of License Agreements NumberOfLicenseAgreements	2	Agreement
CY2015Q1	scyx	Number Of License Agreements NumberOfLicenseAgreements	2	Agreement
CY2014Q2	scyx	Offering Expenses OfferingExpenses	4127000	USD
CY2013Q4	scyx	Prepaid Researchand Development Expenses Current PrepaidResearchandDevelopmentExpensesCurrent	0	USD
CY2014Q4	scyx	Prepaid Researchand Development Expenses Current PrepaidResearchandDevelopmentExpensesCurrent	109000	USD
CY2013	scyx	Property And Equipment Purchases In Accounts Payable PropertyAndEquipmentPurchasesInAccountsPayable	15000	USD
CY2014Q1	scyx	Property And Equipment Purchases In Accounts Payable PropertyAndEquipmentPurchasesInAccountsPayable	204000	USD
CY2014	scyx	Property And Equipment Purchases In Accounts Payable PropertyAndEquipmentPurchasesInAccountsPayable	34000	USD
CY2015Q1	scyx	Property And Equipment Purchases In Accounts Payable PropertyAndEquipmentPurchasesInAccountsPayable	25000	USD
CY2013Q4	scyx	Property Plantand Equipment Including Assets Heldfor Sale Net PropertyPlantandEquipmentIncludingAssetsHeldforSaleNet	5401000	USD
CY2014Q4	scyx	Property Plantand Equipment Including Assets Heldfor Sale Net PropertyPlantandEquipmentIncludingAssetsHeldforSaleNet	4835000	USD
CY2015Q1	scyx	Property Plantand Equipment Including Assets Heldfor Sale Net PropertyPlantandEquipmentIncludingAssetsHeldforSaleNet	4674000	USD
CY2014Q2	scyx	Researchand Development Arrangement Contractto Performfor Others Period After Notice Required Before Contract Termination ResearchandDevelopmentArrangementContracttoPerformforOthersPeriodAfterNoticeRequiredBeforeContractTermination	P30D
	scyx	Researchand Development Arrangement Contractto Performfor Others Period After Notice Required Before Contract Termination ResearchandDevelopmentArrangementContracttoPerformforOthersPeriodAfterNoticeRequiredBeforeContractTermination	P30D
CY2013	scyx	Researchand Development Expense Gross ResearchandDevelopmentExpenseGross	4363000	USD
CY2014Q1	scyx	Researchand Development Expense Gross ResearchandDevelopmentExpenseGross	1320000	USD
CY2014	scyx	Researchand Development Expense Gross ResearchandDevelopmentExpenseGross	8513000	USD
CY2015Q1	scyx	Researchand Development Expense Gross ResearchandDevelopmentExpenseGross	3981000	USD
CY2013	scyx	Researchand Development Income Reimbursement ResearchandDevelopmentIncomeReimbursement	0	USD
CY2014Q1	scyx	Researchand Development Income Reimbursement ResearchandDevelopmentIncomeReimbursement	0	USD
CY2014	scyx	Researchand Development Income Reimbursement ResearchandDevelopmentIncomeReimbursement	226000	USD
CY2015Q1	scyx	Researchand Development Income Reimbursement ResearchandDevelopmentIncomeReimbursement	194000	USD
CY2013	scyx	Sharebased Compensation Arrangementby Sharebased Payment Award Fair Value Assumptions Expected Forfeiture Rate SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0.05
CY2014	scyx	Sharebased Compensation Arrangementby Sharebased Payment Award Fair Value Assumptions Expected Forfeiture Rate SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0.05
CY2013	scyx	Sharebased Compensation Arrangementby Sharebased Payment Award Options Granted Aggregate Fair Value SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsGrantedAggregateFairValue	290000	USD
CY2014	scyx	Sharebased Compensation Arrangementby Sharebased Payment Award Options Granted Aggregate Fair Value SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsGrantedAggregateFairValue	3249000	USD
CY2013	scyx	Sharebased Goodsand Nonemployee Services Transaction Valuation Method Forfeiture Rate SharebasedGoodsandNonemployeeServicesTransactionValuationMethodForfeitureRate	0.05
CY2014	scyx	Sharebased Goodsand Nonemployee Services Transaction Valuation Method Forfeiture Rate SharebasedGoodsandNonemployeeServicesTransactionValuationMethodForfeitureRate	0.05
CY2013	scyx	Unrecognized Tax Benefits Increase Decreasefrom Other UnrecognizedTaxBenefitsIncreaseDecreasefromOther	0	USD
CY2014	scyx	Unrecognized Tax Benefits Increase Decreasefrom Other UnrecognizedTaxBenefitsIncreaseDecreasefromOther	0	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1521000	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	426000	USD
CY2015Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	903000	USD
CY2013Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	0	USD
CY2014Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1464000	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	732000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2245000	USD
CY2015Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3060000	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17669000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17285000	USD
CY2015Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17608000	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	5168000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	150934000	USD
CY2015Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	151325000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	5714000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	510000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	180000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1201000	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	180000	USD
CY2014Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	110000	USD
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1201000	USD
CY2015Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	296000	USD
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	251000	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	163000	USD
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2013	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	10000	USD
CY2014	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	0	USD
CY2013	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	88000	USD
CY2014	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	163000	USD
CY2013	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3485000	USD
CY2014Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	536000	USD
CY2014	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	755000	USD
CY2015Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
CY2013	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2014	us-gaap	Asset Impairment Charges AssetImpairmentCharges	51000	USD
CY2013Q4	us-gaap	Assets Assets	12387000	USD
CY2014Q4	us-gaap	Assets Assets	39672000	USD
CY2015Q1	us-gaap	Assets Assets	34857000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	8443000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	39647000	USD
CY2015Q1	us-gaap	Assets Current AssetsCurrent	34568000	USD
CY2013Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	6798000	USD
CY2014Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	6701000	USD
CY2015Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	6049000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2385000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1402000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	650000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32243000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27620000	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-983000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-752000	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	30841000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4623000	USD
CY2014Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.20
CY2013Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	13879	shares
CY2014Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	14033	shares
CY2015Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	14033	shares
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	2134277	shares
CY2014Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	847711	shares
CY2015Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	1652499	shares
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	70000000	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2015Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	334068	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8512103	shares
CY2015Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8527210	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	335782	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	334068	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8512103	shares
CY2015Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8527210	shares
CY2013Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	0	USD
CY2014Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	8000	USD
CY2015Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	8000	USD
CY2013	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2014	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	88790000	USD
CY2014Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1691884	shares
CY2013	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	14016000	USD
CY2014	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2013Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2144000	USD
CY2014Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	0	USD
CY2013Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1775000	USD
CY2014Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	0	USD
CY2015Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	257000	USD
CY2013Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	0	USD
CY2014Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	0	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	262000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	257000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	35950000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Financing Costs DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts	800000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Deferred Financing Costs DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts	0	USD
CY2014Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	9998000	USD
CY2014Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	0	USD
CY2014Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	2701000	USD
CY2013	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
CY2014Q1	us-gaap	Dilutive Securities DilutiveSecurities	-2783000	USD
CY2015Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	257000	USD
CY2013Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1144000	USD
CY2014Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	893000	USD
CY2015Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	828000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	26286000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	29981000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	25000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	15000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2373000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2684000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	241000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	336000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	612000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1052000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	30675000	USD
CY2013	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	239000	USD
CY2014	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	239000	USD
CY2014	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.5
CY2014	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.06
CY2013	us-gaap	Depreciation Depreciation	1329000	USD
CY2014Q1	us-gaap	Depreciation Depreciation	308000	USD
CY2014	us-gaap	Depreciation Depreciation	1238000	USD
CY2015Q1	us-gaap	Depreciation Depreciation	323000	USD
CY2013Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	12237000	USD
CY2014	us-gaap	Dilutive Securities DilutiveSecurities	-10080000	USD
CY2015Q1	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
CY2013	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	2.59
CY2014Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	1.10
CY2014	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.24
CY2015Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.05
CY2013	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	2.59
CY2014Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.60
CY2014	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.23
CY2015Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.05
CY2013	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	575000	USD
CY2014Q1	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	313000	USD
CY2014	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	1166000	USD
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.04
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.75
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-139.47
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.57
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.69
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.000
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.005
CY2014	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.070
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies Other EffectiveIncomeTaxRateReconciliationTaxContingenciesOther	-0.020
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies Other EffectiveIncomeTaxRateReconciliationTaxContingenciesOther	0.000
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.75
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.018
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.172
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.340
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.340
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.025
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.000
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.028
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.006
CY2015Q1	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	0	USD
CY2013Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment	5401000	USD
CY2014Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment	4835000	USD
CY2015Q1	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment	4674000	USD
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-139.47
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.65
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.779
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.029
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.000
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization	-0.012
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization	0.000
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.001
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.040
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.000
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.047
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	61000	USD
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	156000	USD
CY2013	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y9M18D
CY2014	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y2M12D
CY2013Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	404000	USD
CY2014Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	2683000	USD
CY2013	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2014Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2014	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2015Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2014Q2	us-gaap	Expense Related To Distribution Or Servicing And Underwriting Fees ExpenseRelatedToDistributionOrServicingAndUnderwritingFees	3290000	USD
CY2013	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	7886000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-142.06
CY2014Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-7.17
CY2014	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-2.92
CY2015Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.70
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	870000	USD
CY2014Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2783000	USD
CY2014	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-10080000	USD
CY2015Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2013	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	5382000	USD
CY2014Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	544000	USD
CY2014	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	544000	USD
CY2012Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	683000	USD
CY2013Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	12237000	USD
CY2014Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	9998000	USD
CY2014Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
CY2013	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	988000	USD
CY2014	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2013	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2014	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1389000	USD
CY2013	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-31331000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	45000	USD
CY2014	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-5603000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-5931000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-31906000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-268000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6769000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5931000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-142.06
CY2014Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-4.75
CY2014	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.28
CY2015Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.70
CY2014Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	367000	USD
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	1369000	USD
CY2015Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-453000	USD
CY2014Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-575000	USD
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-313000	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1166000	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-794000	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	5275000	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	936000	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	USD
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-10848000	USD
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2301000	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	392000	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Amortization IncomeTaxReconciliationNondeductibleExpenseAmortization	0	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	41000	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	268000	USD
CY2013	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-5000	USD
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-190000	USD
CY2014Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1047000	USD
CY2014	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-35000	USD
CY2013	us-gaap	Insured Event Gain Loss InsuredEventGainLoss	0	USD
CY2014	us-gaap	Insured Event Gain Loss InsuredEventGainLoss	165000	USD
CY2013	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	892000	USD
CY2014	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	0	USD
CY2013	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-190000	USD
CY2014	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	0	USD
CY2013	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-116000	USD
CY2014	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-471000	USD
CY2013	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	623000	USD
CY2014	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	0	USD
CY2013	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	0	USD
CY2014	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	320000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-82000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	635000	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1575000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1052000	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1366000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	275000	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	439000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-448000	USD
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1449000	USD
CY2015Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-65000	USD
CY2013	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	892000	USD
CY2014	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	USD
CY2013	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	102000	USD
CY2014Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-186000	USD
CY2014	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	490000	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	160000	USD
CY2013	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2014Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	274988	shares
CY2014	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	273776	shares
CY2015Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2013	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-192000	USD
CY2014Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-44000	USD
CY2014	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-48000	USD
CY2015Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1000	USD
CY2013	us-gaap	Interest Paid InterestPaid	197000	USD
CY2014Q1	us-gaap	Interest Paid InterestPaid	45000	USD
CY2014	us-gaap	Interest Paid InterestPaid	49000	USD
CY2015Q1	us-gaap	Interest Paid InterestPaid	0	USD
CY2013Q4	us-gaap	Interest Payable Current InterestPayableCurrent	23000	USD
CY2014Q4	us-gaap	Interest Payable Current InterestPayableCurrent	0	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	906000	USD
CY2014Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	231000	USD
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	952000	USD
CY2015Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	218000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	33339000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	6241000	USD
CY2015Q1	us-gaap	Liabilities Liabilities	7419000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12387000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	39672000	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34857000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	19958000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5348000	USD
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6591000	USD
CY2013Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	2443000	USD
CY2014Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	2420000	USD
CY2015Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	2371000	USD
CY2013	us-gaap	License And Services Revenue LicenseAndServicesRevenue	95000	USD
CY2014Q1	us-gaap	License And Services Revenue LicenseAndServicesRevenue	93000	USD
CY2014	us-gaap	License And Services Revenue LicenseAndServicesRevenue	256000	USD
CY2015Q1	us-gaap	License And Services Revenue LicenseAndServicesRevenue	96000	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	15000000	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	2767000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-839000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	40801000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	95000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	557000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-74000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-488000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-171000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4307000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	161000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-9472000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4547000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-30461000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	412000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-4234000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-6384000	USD
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-46809000	USD
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1221000	USD
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5867000	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6384000	USD
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-46809000	USD
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-4004000	USD
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-15947000	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-6384000	USD
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-23257000	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2193000	USD
CY2014	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7878000	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1075000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	291000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	291000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1156000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1161000	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	431000	USD
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	74000	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	704000	USD
CY2015Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	171000	USD
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	5000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	25000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	25000	USD
CY2015Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	32000	USD
CY2014	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2013	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	0	USD
CY2013Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	0	USD
CY2014Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	226000	USD
CY2015Q1	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	420000	USD
CY2013	us-gaap	Operating Expenses OperatingExpenses	8744000	USD
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	2526000	USD
CY2014	us-gaap	Operating Expenses OperatingExpenses	15903000	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	5997000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-8649000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2461000	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-14647000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5932000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	4749000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	4540000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1123000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1140000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1104000	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1122000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	826000	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	556000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	332000	USD
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2014Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10000	USD
CY2014	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10000	USD
CY2015Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2013Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	141000	USD
CY2014Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	70000	USD
CY2013	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	542000	USD
CY2014Q1	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	1388000	USD
CY2014	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	6875000	USD
CY2015Q1	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	0	USD
CY2014	us-gaap	Payments For Restructuring PaymentsForRestructuring	362000	USD
CY2013	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	95000	USD
CY2014	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2014Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5000	USD
CY2014	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	9000	USD
CY2015Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2013	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	243000	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	703000	USD
CY2015Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	899000	USD
CY2013Q4	us-gaap	Prepaid Insurance PrepaidInsurance	97000	USD
CY2014Q4	us-gaap	Prepaid Insurance PrepaidInsurance	295000	USD
CY2013	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	899000	USD
CY2014	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2013	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	USD
CY2014	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	216000	USD
CY2014Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	54583000	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		USD
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	62000000	USD
CY2013	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	2500000	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	544000	USD
CY2014	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	544000	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
CY2013	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	0	USD
CY2014Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	0	USD
CY2014	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	68000	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	95000	USD
CY2012Q3	us-gaap	Proceeds From License Fees Received ProceedsFromLicenseFeesReceived	313000	USD
CY2013Q3	us-gaap	Proceeds From License Fees Received ProceedsFromLicenseFeesReceived	1500000	USD
CY2014Q1	us-gaap	Proceeds From License Fees Received ProceedsFromLicenseFeesReceived	500000	USD
CY2013	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt		USD
CY2014	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	-15000000	USD
CY2014	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	0	USD
CY2015Q1	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	0	USD
CY2013	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	988000	USD
CY2014	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	0	USD
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5000	USD
CY2014	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	55000	USD
CY2013	us-gaap	Profit Loss ProfitLoss	-30461000	USD
CY2014Q1	us-gaap	Profit Loss ProfitLoss	412000	USD
CY2014	us-gaap	Profit Loss ProfitLoss	-4234000	USD
CY2015Q1	us-gaap	Profit Loss ProfitLoss	-6384000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23070000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	22120000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	22282000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	USD
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	USD
CY2013	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2014	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	500000	USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4363000	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1320000	USD
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8287000	USD
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3787000	USD
CY2014Q4	us-gaap	Restructuring Reserve RestructuringReserve	17000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-113277000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-117511000	USD
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-123895000	USD
CY2013	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	7288000	USD
CY2014Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	1822000	USD
CY2014	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	7288000	USD
CY2015Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	987000	USD
CY2013	us-gaap	Revenues Revenues	95000	USD
CY2014Q1	us-gaap	Revenues Revenues	65000	USD
CY2014	us-gaap	Revenues Revenues	1256000	USD
CY2015Q1	us-gaap	Revenues Revenues	65000	USD
CY2013	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4381000	USD
CY2014Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1206000	USD
CY2014	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7616000	USD
CY2015Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2210000	USD
CY2014Q2	us-gaap	Severance Costs1 SeveranceCosts1	379000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0241
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0205
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.6549
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.6857
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	6000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	11000	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	20.81
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	9.57
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	27972	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	42759	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	11525	shares
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	520887	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	25.09
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.24
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	213000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3097000	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	265000	USD
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	154277	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	137610	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	615322	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	23.05
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	25.86
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.55
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	2898000	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	88000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	115475	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	192916	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	23.26
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	9.44
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	3084000	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	247000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	136002	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	572926	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	25.70
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	9.55
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	21.01
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	20.40
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	50.39
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	9.53
CY2014Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	192916	shares
CY2014Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	615322	shares
CY2015Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	575416	shares
CY2013	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate	0
CY2014	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate	0
CY2013	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Term1 ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1	P5Y
CY2014	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Term1 ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1	P5Y3M17D
CY2013	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Volatility Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate	0.6549
CY2014	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Volatility Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate	0.6410
CY2013	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Risk Free Interest Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate	0.0237
CY2014	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Risk Free Interest Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate	0.0175
CY2014Q2	us-gaap	Share Price SharePrice	10.00
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y5M27D
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y0M15D
CY2013Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	22135	shares
CY2014Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	422407	shares
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y0M7D
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y2M23D
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y5M23D
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P4Y6M
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P9Y5M23D
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y2M5D
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P9Y5M23D
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	801000	USD
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	458000	USD
CY2014Q4	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	0	USD
CY2014Q2	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	1691884	shares
CY2014	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	1691884	shares
CY2014	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	10048	shares
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	623000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	623000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	333000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2015Q1	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	15107	shares
CY2014Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6200000	shares
CY2014	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6200000	shares
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	220	shares
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	416	shares
CY2014	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	88790000	USD
CY2014	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	68000	USD
CY2014	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	54583000	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5000	USD
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	9000	USD
CY2013	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1934	shares
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	-65415000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	-108109000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	33431000	USD
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	27438000	USD
CY2014Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.25
CY2014Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.196
CY2014Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-4 reverse stock split
CY2015Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-4 reverse stock split
CY2013	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	5714000	USD
CY2014Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	510000	USD
CY2014	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	510000	USD
CY2015Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	0	USD
CY2013	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	5714000	USD
CY2014Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	510000	USD
CY2014	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	510000	USD
CY2015Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	USD
CY2014Q2	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	29135824	shares
CY2014Q2	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	17803273	shares
CY2014Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	17803273	shares
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	290000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	USD
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	335612	shares
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	609074	shares
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5937087	shares
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8516467	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	335612	shares
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	334086	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5663311	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8516467	shares
CY2014	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;padding-left:0px;text-indent:30px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-style:italic;font-weight:normal;text-decoration:none;">Concentration of Credit Risk</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:6px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Financial instruments, which potentially expose the Company to concentrations of credit risk, consist principally of cash on deposit with a bank, which exceeds FDIC insured limits, and accounts receivable and unbilled services. Ongoing credit evaluations of customer’s financial condition are performed by the Company and collateral is not required.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:6px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"></font></div></div>
CY2014	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;padding-left:0px;text-indent:30px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-style:italic;font-weight:normal;text-decoration:none;">Revenue Recognition and Deferred Revenue</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company has historically derived the majority of its revenue from providing contract research and development services under fee for service arrangements, which were provided by the Services Business that was sold in July 2015 (see Notes 19 and 20). The Company also has entered into collaboration arrangements in exchange for non-refundable upfront payments and consideration as services are performed. These arrangements include multiple elements, such as the sale of licenses and the provision of services. Under these arrangements, the Company also is entitled to receive development milestone payments and royalties in the form of a designated percentage of product sales. The Company classifies non-refundable upfront payments, milestone payments and royalties received under collaboration and licensing agreements as revenues within its statements of operations because the Company views such activities as being central to its business operations.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Revenue is recognized when all of the following conditions are met: (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred or services have been rendered; (iii) fees are fixed or determinable; and (iv) collection of fees is reasonably assured. The Company’s contract research and development services revenue is recognized in the period in which the services are performed. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">When entering into an arrangement, the Company first determines whether the arrangement includes multiple deliverables and is subject to accounting guidance in ASC subtopic 605-25, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:italic;">Multiple-Element Arrangements</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">. If the Company determines that an arrangement includes multiple elements, it determines whether the arrangement should be divided into separate units of accounting and how the arrangement consideration should be measured and allocated among the separate units of accounting. An element qualifies as a separate unit of accounting when the delivered element has standalone value to the customer. The Company’s arrangements do not include a general right of return relative to delivered elements. Any delivered elements that do not qualify as separate units of accounting are combined with other undelivered elements within the arrangement as a single unit of accounting. If the arrangement constitutes a single combined unit of accounting, the Company determines the revenue recognition method for the combined unit of accounting and recognizes the revenue over the period from inception through the date the last deliverable within the single unit of accounting is delivered.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Non-refundable upfront license fees are recorded as deferred revenue and recognized into revenue on a straight-line basis over the estimated period of the Company’s substantive performance obligations. If the Company does not have substantive performance obligations, the Company recognizes non-refundable upfront fees into revenue through the date the deliverable is satisfied. Analyzing the arrangement to identify deliverables requires the use of judgment and each deliverable may be an obligation to deliver services, a right or license to use an asset, or another performance obligation. In arrangements that include license rights and other non-contingent deliverables, such as participation in a steering committee, these deliverables do not have standalone value because the non-contingent deliverables are dependent on the license rights. That is, the non-contingent deliverables would not have value without the license rights, and only the Company can perform the related services. Upfront license rights and non-contingent deliverables, such as participation in a steering committee, do not have standalone value as they are not sold separately and they cannot be resold. In addition, when non-contingent deliverables are sold with upfront license rights, the license rights do not represent the culmination of a separate earnings process. As such, the Company accounts for the license and the non-contingent deliverables as a single combined unit of accounting. In such instances, the license revenue in the form of non-refundable upfront payments is deferred and recognized over the applicable relationship period, which historically has been the estimated period of the Company’s substantive performance obligations or the period the rights granted are in effect. The Company recognizes contingent event-based payments under license agreements when the payments are received. The Company has not received any royalty payments to date.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company will recognize a milestone payment as revenue when earned if it is substantive and the Company has </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">no</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> ongoing performance obligations related to the milestone. A milestone payment is considered substantive if it: 1) is commensurate with either the Company’s performance to achieve the milestone or the enhanced value of the delivered item as a result of a specific outcome from the Company’s performance to achieve the milestone; 2) relates solely to past performance; and 3) is reasonable relative to all of the deliverables and payment terms, including other potential milestone consideration, within the arrangement.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Amounts received prior to satisfying all revenue recognition criteria are recorded as deferred revenue in the accompanying balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company’s deferred revenue includes non-refundable upfront payments received under certain licensing and collaboration arrangements that contain substantive prospective performance obligations that the Company is providing over respective defined service or estimated relationship periods. Such non-refundable upfront payments are recognized over these defined service or estimated relationship periods. The Company received a non-refundable upfront payment of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$1,500</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> from R-Pharm in August 2013 which is being recognized over a period of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">70</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> months. The Company recognized revenue in continuing operations from this upfront payment of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$256</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$95</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> for the </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">years ended December 31, 2014 and 2013</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">, respectively. The Company received a non-refundable upfront payments of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$313</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$500</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> in August 2012 and January 2014, respectively, under research services agreements supported by the Services Business, which were being recognized over periods of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">six</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> months and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">48</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> months, respectively. The Company recognized revenue in discontinued operations from these upfront payments of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$122</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$62</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> for the </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">years ended December 31, 2014 and 2013</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">, respectively.</font></div><div style="line-height:120%;padding-top:8px;padding-left:0px;text-indent:30px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-style:italic;font-weight:normal;text-decoration:none;"></font></div></div>
CY2015Q1	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;padding-left:0px;text-indent:30px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-style:italic;font-weight:normal;text-decoration:none;">Revenue Recognition and Deferred Revenue</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company has historically derived the majority of its revenue from providing contract research and development services under fee for service arrangements, which were provided by the Services Business that was sold in July 2015 (see Notes 13 and 14). The Company also has entered into collaboration arrangements in exchange for non-refundable upfront payments and consideration as services are performed. These arrangements include multiple elements, such as the sale of licenses and the provision of services. Under these arrangements, the Company also is entitled to receive development milestone payments and royalties in the form of a designated percentage of product sales. The Company classifies non-refundable upfront payments, milestone payments and royalties received under collaboration and licensing agreements as revenue within its statements of operations because the Company views such activities as being central to its business operations.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Revenue is recognized when all of the following conditions are met: (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been rendered, (iii) fees are fixed or determinable, and (iv) collection of fees is reasonably assured. The Company’s contract research and development services revenue is recognized in the period in which the services are performed. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">When entering into an arrangement, the Company first determines whether the arrangement includes multiple deliverables and is subject to accounting guidance in ASC subtopic 605-25, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:italic;">Multiple-Element Arrangements</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">. If the Company determines that an arrangement includes multiple elements, it determines whether the arrangement should be divided into separate units of accounting and how the arrangement consideration should be measured and allocated among the separate units of accounting. An element qualifies as a separate unit of accounting when the delivered element has standalone value to the customer. The Company’s arrangements do not include a general right of return relative to delivered elements. Any delivered elements that do not qualify as separate units of accounting are combined with other undelivered elements within the arrangement as a single unit of accounting. If the arrangement constitutes a single combined unit of accounting, the Company determines the revenue recognition method for the combined unit of accounting and recognizes the revenue over the period from inception through the date the last deliverable within the single unit of accounting is delivered.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Non-refundable upfront license fees are recorded as deferred revenue and recognized into revenue on a straight-line basis over the estimated period of the Company’s substantive performance obligations. If the Company does not have substantive performance obligations, the Company recognizes non-refundable upfront fees into revenue through the date the deliverable is satisfied. Analyzing the arrangement to identify deliverables requires the use of judgment and each deliverable may be an obligation to deliver services, a right or license to use an asset, or another performance obligation. In arrangements that include license rights and other non-contingent deliverables, such as participation in a steering committee, these deliverables do not have standalone value because the non-contingent deliverables are dependent on the license rights. That is, the non-contingent deliverables would not have value without the license rights, and only the Company can perform the related services. Upfront license rights and non-contingent deliverables, such as participation in a steering committee, do not have standalone value as they are not sold separately and they cannot be resold. In addition, when non-contingent deliverables are sold with upfront license rights, the license rights do not represent the culmination of a separate earnings process. As such, the Company accounts for the license and the non-contingent deliverables as a single combined unit of accounting. In such instances, the license revenue in the form of non-refundable upfront payments is deferred and recognized over the applicable relationship period, which historically has been the estimated period of the Company’s substantive performance obligations or the period the rights granted are in effect. The Company recognizes contingent event-based payments under license agreements when the payments are received. The Company has not received any royalty payments to date.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company will recognize a milestone payment as revenue when earned if it is substantive and the Company has </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">no</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> ongoing performance obligations related to the milestone. A milestone payment is considered substantive if it: 1) is commensurate with either the Company’s performance to achieve the milestone or the enhanced value of the delivered item as a result of a specific outcome from the Company’s performance to achieve the milestone; 2) relates solely to past performance; and 3) is reasonable relative to all of the deliverables and payment terms, including other potential milestone consideration, within the arrangement.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Amounts received prior to satisfying all revenue recognition criteria are recorded as deferred revenue in the accompanying balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company’s deferred revenue includes non-refundable upfront payments received under certain licensing and collaboration arrangements that contain substantive prospective performance obligations that the Company is providing over respective defined service or estimated relationship periods. Such non-refundable upfront payments are recognized as revenue over these defined service or estimated relationship periods. The Company received non-refundable upfront payments under research services agreements supported by the Services Business of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$313</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$1,500</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$500</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> in August 2012, August 2013 and January 2014, respectively, which are recognized as revenue over periods of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">six</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> months, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">70</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> months and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">48</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> months, respectively. The Company recognized revenue in discontinued operations from these upfront payments of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$96</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">$93</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">for the three months ended</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">March 31, 2015</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> and 2014, respectively.</font></div></div>

Files In Submission

Name	View Source	Status
0001178253-15-000118-index-headers.html	Edgar Link	pending
0001178253-15-000118-index.html	Edgar Link	pending
0001178253-15-000118.txt	Edgar Link	pending
0001178253-15-000118-xbrl.zip	Edgar Link	pending
exhibit231.htm	Edgar Link	pending
exhibit991.htm	Edgar Link	pending
exhibit992.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
form8-kitems801and901.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
report.css	Edgar Link	pending
scyx-20151030.xml	Edgar Link	completed
scyx-20151030.xsd	Edgar Link	pending
scyx-20151030_cal.xml	Edgar Link	unprocessable
scyx-20151030_def.xml	Edgar Link	unprocessable
scyx-20151030_lab.xml	Edgar Link	unprocessable
scyx-20151030_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCYX
SCYNEXIS Inc Stock $scyx

2015 Q1 Form 8-K Financial Statement

#000117825315000118 Filed on October 30, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCYX SCYNEXIS Inc Stock $scyx

2015 Q1 Form 8-K Financial Statement

#000117825315000118 Filed on October 30, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCYX
SCYNEXIS Inc Stock $scyx